Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
Journal
The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
received:
28
07
2020
accepted:
08
02
2021
pubmed:
27
3
2021
medline:
26
10
2021
entrez:
26
3
2021
Statut:
ppublish
Résumé
Nonalcoholic fatty liver disease (NAFLD), as the most common liver disease in the world, can range from simple steatosis to steatohepatitis. We evaluated the association between meat consumption and risk of NAFLD in the Golestan Cohort Study (GCS). The GCS enrolled 50,045 participants, aged 40-75 years in Iran. Dietary information was collected using a 116-item semiquantitative food frequency questionnaire at baseline (2004-2008). A random sample of 1,612 cohort members participated in a liver-focused study in 2011. NAFLD was ascertained through ultrasound. Total red meat consumption and total white meat consumption were categorized into quartiles based on the GCS population, with the first quartile as the referent group. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). The median intake of total red meat was 17 and total white meat was 53 g/d. During follow-up, 505 individuals (37.7%) were diagnosed with NAFLD, and 124 of them (9.2%) had elevated alanine transaminase. High total red meat consumption (ORQ4 vs Q1 = 1.59, 95% CI = 1.06-2.38, P trend = 0.03) and organ meat consumption (ORQ4 vs Q1 = 1.70, 95% CI = 1.19-2.44, P trend = 0.003) were associated with NAFLD. Total white meat, chicken, or fish consumption did not show significant associations with NAFLD. In this population with low consumption of red meat, individuals in the highest group of red meat intake were at increased odds of NAFLD. Furthermore, this is the first study to show an association between organ meat consumption and NAFLD (see Visual Abstract, http://links.lww.com/AJG/B944).
Identifiants
pubmed: 33767101
doi: 10.14309/ajg.0000000000001229
pii: 00000434-202108000-00020
pmc: PMC8460710
mid: NIHMS1732206
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1667-1675Subventions
Organisme : Intramural NIH HHS
ID : ZIA CP000101
Pays : United States
Organisme : Cancer Research UK
Pays : United Kingdom
Informations de copyright
Copyright © 2021 by The American College of Gastroenterology.
Références
European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6):1388–402.
Li B, Zhang C, Zhan YT. Nonalcoholic fatty liver disease cirrhosis: A review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol 2018;2018:2784537.
Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34(3):274–85.
Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148(3):547–55.
GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2020;5(3):245–66.
Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15(1):11–20.
Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int 2017;37(7):936–49.
Della Pepa G, Vetrani C, Lombardi G, et al. Isocaloric dietary changes and non-alcoholic fatty liver disease in high cardiometabolic risk individuals. Nutrients 2017;9(10):1065.
Eslamparast T, Tandon P, Raman M. Dietary composition independent of weight loss in the management of non-alcoholic fatty liver disease. Nutrients 2017;9(8):800.
Miele L, Dall'armi V, Cefalo C, et al. A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease. Genes Nutr 2014;9(2):383.
Zelber-Sagi S, Ivancovsky-Wajcman D, Fliss Isakov N, et al. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J Hepatol 2018;68(6):1239–46.
Noureddin M, Zelber-Sagi S, Wilkens LR, et al. Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: The multiethnic cohort. Hepatology 2020;71(6):1940–52.
Merat S, Poustchi H, Hemming K, et al. PolyPill for prevention of cardiovascular disease in an urban Iranian population with special focus on nonalcoholic steatohepatitis: A pragmatic randomized controlled trial within a cohort (PolyIran—liver)—study protocol. Arch Iran Med 2015;18(8):515–23.
Pourshams A, Khademi H, Malekshah AF, et al. Cohort Profile: The Golestan Cohort Study—a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 2010;39(1):52–9.
Sheikh M, Poustchi H, Pourshams A, et al. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan cohort study. Gastroenterology 2019;156(5):1416–27.
Roshandel G, Khoshnia M, Poustchi H, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): A pragmatic, cluster-randomised trial. Lancet 2019;394(10199):672–83.
Freedman LS, Midthune D, Carroll RJ, et al. Adjustments to improve the estimation of usual dietary intake distributions in the population. J Nutr 2004;134(7):1836–43.
Malekshah AF, Kimiagar M, Saadatian-Elahi M, et al. Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: Pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr 2006;60(8):971–7.
Hashemian M, Farvid MS, Poustchi H, et al. The application of six dietary scores to a middle eastern population: A comparative analysis of mortality in a prospective study. Eur J Epidemiol 2019;34(4):371–82.
Etemadi A, Khademi H, Kamangar F, et al. Hazards of cigarettes, smokeless tobacco and waterpipe in a middle eastern population: A cohort study of 50 000 individuals from Iran. Tob Control 2017;26(6):674–82.
Sheikh M, Shakeri R, Poustchi H, et al. Opium use and subsequent incidence of cancer: Results from the Golestan cohort study. Lancet Glob Health 2020;8(5):e649–e60.
Islami F, Kamangar F, Nasrollahzadeh D, et al. Socio-economic status and oesophageal cancer: Results from a population-based case-control study in a high-risk area. Int J Epidemiol 2009;38(4):978–88.
Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102(12):2708–15.
Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: A practical approach to diagnosis and staging. Frontline Gastroenterol 2014;5(3):211–8.
Red Meat and Processed Meat. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer: Lyon, France, 2018.
Alferink LJ, Kiefte-de Jong JC, Erler NS, et al. Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: The Rotterdam study. Gut 2019;68(6):1088–98.
Shi L, Liu ZW, Li Y, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci 2012;25(4):383–91.
Etemadi A, Sinha R, Ward MH, et al. Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP diet and Health study: Population based cohort study. BMJ 2017;357:j1957.
Hassani Zadeh S, Mansoori A, Hosseinzadeh M. Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Gastroenterol Hepatol 2020. [Epub ahead of print December 2, 2020.]
Babio N, Sorli M, Bullo M, et al. Association between red meat consumption and metabolic syndrome in a mediterranean population at high cardiovascular risk: Cross-sectional and 1-year follow-up assessment. Nutr Metab Cardiovasc Dis 2012;22(3):200–7.
Moore JB. Non-alcoholic fatty liver disease: The hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 2010;69(2):211–20.
Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19(5):576–85.
Dumas ME, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006;103(33):12511–6.
Foerster J, Maskarinec G, Reichardt N, et al. The influence of whole grain products and red meat on intestinal microbiota composition in normal weight adults: A randomized crossover intervention trial. PLoS One 2014;9(10):e109606.
Kugelberg E. Red meat consumption leads to a microbiota-dependent risk of cardiovascular disease. Nat Rev Endocrinol 2013;9:378.
Kolodziejczyk AA, Zheng D, Shibolet O, et al. The role of the microbiome in NAFLD and NASH. EMBO Mol Med 2019;11(2):e9302.
Bakhshimoghaddam F, Shateri K, Sina M, et al. Daily consumption of synbiotic yogurt decreases liver steatosis in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. J Nutr 2018;148(8):1276–84.
Ji S, Wang F, Chen Y, et al. Developmental changes in the level of free and conjugated sialic acids, Neu5Ac, Neu5Gc and KDN in different organs of pig: A LC-MS/MS quantitative analyses. Glycoconj J 2017;34(1):21–30.
Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 2007;47(5):711–7.
Argo CK, Patrie JT, Lackner C, et al. Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial. J Hepatol 2015;62(1):190–7.
Suarez M, Boque N, Del Bas JM, et al. Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease. Nutrients 2017;9(10):1052.
Cocate PG, Natali AJ, de Oliveira A, et al. Red but not white meat consumption is associated with metabolic syndrome, insulin resistance and lipid peroxidation in Brazilian middle-aged men. Eur J Prev Cardiol 2015;22(2):223–30.
Feskens EJ, Sluik D, van Woudenbergh GJ. Meat consumption, diabetes, and its complications. Curr Diab Rep 2013;13(2):298–306.
Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37(6):1286–92.